HemaSphere (Aug 2023)
S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES
- Stacey Dillon,
- Rupert Davies,
- Jason Lickliter,
- Kristi Mclendon,
- Kristi Kristi L. Manjarrez, Bs,
- Alina Smith,
- Krystalyn Hudson,
- Lori Blanchfield,
- Russel Sanderson,
- Allison Chunyk,
- Tiffany Blair,
- Amanda Enstrom,
- Hany Zayed,
- Stanford Peng
Affiliations
- Stacey Dillon
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Rupert Davies
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Jason Lickliter
- 2 Nucleus Network Melbourne Clinic, Melbourne, Australia
- Kristi Mclendon
- 3 Nucleus Network Brisbane Clinic, Herston, Australia
- Kristi Kristi L. Manjarrez, Bs
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Alina Smith
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Krystalyn Hudson
- 4 Columbia University, New York, United States
- Lori Blanchfield
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Russel Sanderson
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Allison Chunyk
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Tiffany Blair
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Amanda Enstrom
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Hany Zayed
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- Stanford Peng
- 1 Alpine Immune Sciences, Inc., Seattle, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000968016.33010.55
- Journal volume & issue
-
Vol. 7
p. e3301055
Abstract
No abstracts available.